Multikinase inhibitor regorafenib inhibits the growth and metastasis of colon cancer with abundant stroma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Multikinase inhibitor regorafenib inhibits the growth and metastasis of colon cancer with abundant stroma

Published:2016-03-18 Issue:5 Volume:107 Page:601-608
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Takigawa Hidehiko¹,Kitadai Yasuhiko¹,Shinagawa Kei²,Yuge Ryo¹,Higashi Yukihito³,Tanaka Shinji⁴,Yasui Wataru⁵,Chayama Kazuaki¹

Affiliation:

1. Department of Gastroenterology and Metabolism Hiroshima University Hiroshima Japan

2. Department of Endoscopy Hiroshima Prefectural Hospital Hiroshima Japan

3. Department of Cardiovascular Physiology and Medicine Hiroshima University Hiroshima Japan

4. Department of Endoscopy Hiroshima University Hospital Hiroshima Japan

5. Department of Molecular Pathology Hiroshima University Hiroshima Japan

Funder

Ministry of Education, Culture, Science, Sports and Technology of Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.12907

Reference54 articles.

1. Global cancer statistics

2. Functional Imaging of Colorectal Cancer: Positron Emission Tomography, Magnetic Resonance Imaging, and Computed Tomography

3. Survival from colorectal cancer in Germany in the early 21st century

4. Cancer treatment and survivorship statistics, 2012

5. Cancer-related inflammation

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small-molecule-based targeted therapy in liver cancer;Molecular Therapy;2024-08

2. Regorafenib synergizes with TAS102 against multiple gastrointestinal cancers and overcomes cancer stemness, trifluridine-induced angiogenesis, ERK1/2 and STAT3 signaling regardless of KRAS or BRAF mutational status;Oncotarget;2024-07-02

3. Analysis of anti-tumor effect and mechanism of GLS1 inhibitor CB-839 in colorectal cancer using a stroma-abundant tumor model;Experimental and Molecular Pathology;2024-06

4. Lymphatic vessel: Origin, heterogeneity, biological functions and therapeutic targets;Signal Transduction and Targeted Therapy;2024-01-03

5. Novel Immunotherapy Approaches in Colorectal Cancer;Interdisciplinary Cancer Research;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3